Zesiewicz T - Search Results

1

Strong correlations among four measures of disease progression in Friedreich's ataxia.

Saal HJ, Heerinckx F, Zawadzki R, Omidvar O, Kilpatrick M, Zesiewicz T. Saal HJ, et al. Among authors: zesiewicz t. Mov Disord. 2018 Jul;33(6):1021-1022. doi: 10.1002/mds.27351. Epub 2018 Apr 6. Mov Disord. 2018. PMID: 29624733 No abstract available.

2

Sertraline for the treatment of depression in Parkinson's disease.

Hauser RA, Zesiewicz TA. Hauser RA, et al. Among authors: zesiewicz ta. Mov Disord. 1997 Sep;12(5):756-9. doi: 10.1002/mds.870120522. Mov Disord. 1997. PMID: 9380061 Clinical Trial.

3

Pramipexole-induced somnolence and episodes of daytime sleep.

Hauser RA, Gauger L, Anderson WM, Zesiewicz TA. Hauser RA, et al. Among authors: zesiewicz ta. Mov Disord. 2000 Jul;15(4):658-63. doi: 10.1002/1531-8257(200007)15:4<658::aid-mds1009>3.0.co;2-n. Mov Disord. 2000. PMID: 10928575 Clinical Trial.

4

Modafinil treatment of pramipexole-associated somnolence.

Hauser RA, Wahba MN, Zesiewicz TA, McDowell Anderson W. Hauser RA, et al. Among authors: zesiewicz ta. Mov Disord. 2000 Nov;15(6):1269-71. doi: 10.1002/1531-8257(200011)15:6<1269::aid-mds1036>3.0.co;2-r. Mov Disord. 2000. PMID: 11104221 No abstract available.

5

Chorea in a patient with cerebral palsy: treatment with levetiracetam.

Recio MV, Hauser RA, Louis ED, Radhashakar H, Sullivan KL, Zesiewicz TA. Recio MV, et al. Mov Disord. 2005 Jun;20(6):762-4. doi: 10.1002/mds.20414. Mov Disord. 2005. PMID: 15747368

6

A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.

Zesiewicz TA, Ward CL, Hauser RA, Sanchez-Ramos J, Staffetti JF, Sullivan KL. Zesiewicz TA, et al. Mov Disord. 2007 Jan 15;22(2):279-82. doi: 10.1002/mds.21282. Mov Disord. 2007. PMID: 17149715 Clinical Trial.

7

A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor.

Zesiewicz TA, Ward CL, Hauser RA, Salemi JL, Siraj S, Wilson MC, Sullivan KL. Zesiewicz TA, et al. Mov Disord. 2007 Aug 15;22(11):1660-3. doi: 10.1002/mds.21629. Mov Disord. 2007. PMID: 17580330 Clinical Trial.

8

Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease.

Hauser RA, Panisset M, Abbruzzese G, Mancione L, Dronamraju N, Kakarieka A; FIRST-STEP Study Group. Hauser RA, et al. Mov Disord. 2009 Mar 15;24(4):541-50. doi: 10.1002/mds.22343. Mov Disord. 2009. PMID: 19058133 Clinical Trial.

9

Randomized, clinical trial of RT001: Early signals of efficacy in Friedreich's ataxia.

Zesiewicz T, Heerinckx F, De Jager R, Omidvar O, Kilpatrick M, Shaw J, Shchepinov MS. Zesiewicz T, et al. Mov Disord. 2018 Jul;33(6):1000-1005. doi: 10.1002/mds.27353. Epub 2018 Apr 6. Mov Disord. 2018. PMID: 29624723 Clinical Trial.

10

Double-blind, randomized and controlled trial of EPI-743 in Friedreich's ataxia.

Zesiewicz T, Salemi JL, Perlman S, Sullivan KL, Shaw JD, Huang Y, Isaacs C, Gooch C, Lynch DR, Klein MB. Zesiewicz T, et al. Neurodegener Dis Manag. 2018 Aug;8(4):233-242. doi: 10.2217/nmt-2018-0013. Epub 2018 Jul 27. Neurodegener Dis Manag. 2018. PMID: 30051753 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page